Strados Labs is at the forefront of respiratory health innovation with its groundbreaking RESP® Biosensor, the first FDA-cleared wearable stethoscope designed to monitor lung sounds and symptoms such as coughs and wheezes. This pioneering device enables continuous real-time monitoring, providing healthcare providers with invaluable data that enhances patient care from hospital to home. By capturing over 600,000 validated cough events and 19 million breaths across four continents and 35 languages, Strados Labs has established itself as a leader in respiratory technology.

Founded with a mission to "Make Every Breath Count," Strados Labs combines advanced digital acoustics with user-friendly technology to improve outcomes for patients suffering from chronic conditions like asthma and COPD. Their award-winning solution leverages a discreet wearable device and a supportive mobile app that securely tracks lung sound events, ensuring comprehensive insights into patient health. With a commitment to privacy and clinical validation against industry standards, Strados Labs is revolutionizing how lung health is monitored and managed globally.